Decorin in atherosclerosis

Therapeutic Advances in Cardiovascular Disease

Volumn 5, Issue 6, 2011, Pages 305-314

  Singla, Sandeep ^a   Hu, Changping ^b   Mizeracki, Adam ^c   Mehta, Jawahar L ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; coronary artery disease; decorin; extracellular matrix; proteoglycan

Indexed keywords

DECORIN; PROTEOGLYCAN;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; CELL INTERACTION; CEREBROVASCULAR DISEASE; DISEASE MODEL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DECORIN; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MACROPHAGES; PLATELET ACTIVATION; RECEPTORS, SCAVENGER; STENTS;

EID: 83655172356     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944711429715     Document Type: Article

References (55)

1. Al Haj Zen A. Caligiuri G. Sainz J. Lemitre M. Demerens C. Lafont A. (2006) Decorin overexpression reduces atherosclerosis development in apolipoprotein E-deficient mice. Atherosclerosis 187: 31–39.
2. Ameye L. Young M.F. (2002) Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12 (9): 107R–116R.
3. Bernardi B. Guidetti G.F. Campus F. Crittenden J.R. Graybiel A.M. Balduini C. et al. (2006) The small GTPase Rap1b regulates the cross talk between platelet integrin alpha2beta1 and integrin alphaIIbbeta3. Blood 107: 2728–2735.
4. Comalada M. Cardo M. Xaus J. Valledor A.F. Lloberas J. Ventura F. et al. (2003) Decorin reverses the repressive effect of autocrine-produced TGF-beta on mouse macrophage activation. J Immunol 170: 4450–4456.
5. Cutlip D.E. Chauhan M.S. Baim D.S. Ho K.K. Popma J.J. Carrozza J.P. et al. (2002) Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am College Cardiol 40: 2082–2089.
6. Danielson K.G. Baribault H. Holmes D.F. Graham H. Kadler K.E. Iozzo R.V. (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136: 729–743.
7. Edwards I.J. Xu H. Wright M.J. Wagner W.D. (1994) Interleukin-1 upregulates decorin production by arterial smooth muscle cells. Arterioscler Thrombosis 14: 1032–1039.
8. Evanko S.P. Raines E.W. Ross R. Gold L.I. Wight T.N. (1998) Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. Am J Pathol 152: 533–546.
9. Farb A. Kolodgie F.D. Hwang J.Y. Burke A.P. Tefera K. Weber D.K. et al. (2004) Extracellular matrix changes in stented human coronary arteries. Circulation 110: 940–947.
10. Fiedler L.R. Schonherr E. Waddington R. Niland S. Seidler D.G. Aeschlimann D. et al. (2008) Decorin regulates endothelial cell motility on collagen I through activation of insulin-like growth factor I receptor and modulation of alpha2beta1 integrin activity. J Biol Chem 283: 17406–17415.
11. Fischer J.W. Kinsella M.G. Levkau B. Clowes A.W. Wight T.N. (2001) Retroviral overexpression of decorin differentially affects the response of arterial smooth muscle cells to growth factors. Arterioscler Thrombosis Vasc Biol 21: 777–784.
12. Fischer J.W. Steitz S.A. Johnson P.Y. Burke A. Kolodgie F. Virmani R. et al. (2004) Decorin promotes aortic smooth muscle cell calcification and colocalizes to calcified regions in human atherosclerotic lesions. Arterioscler Thrombosis Vasc Biol 24: 2391–2396.
13. Franch R. Chiavegato A. Maraschin M. Candeo S. Ausoni S. Villa A. et al. (2006) Differential availability / processing of decorin precursor in arterial and venous smooth muscle cells. J Anatomy 209: 271–287.
14. Glover C. Ma X. Chen Y.X. Miller H. Veinot J. Labinaz M. et al. (2002) Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation. Am Heart J 144: 702–709.
15. Gotte M. Kresse H. (2005) Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (beta4GalT-7) gene. Biochem Genet 43: 65–77.
16. Grant D.S. Yenisey C. Rose R.W. Tootell M. Santra M. Iozzo R.V. (2002) Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 21: 4765–4777.
17. Guidetti G. Bertoni A. Viola M. Tira E. Balduini C. Torti M. (2002) The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 100: 1707–1714.
18. He F. Zhang Q. Kuruba R. Gao X. Li J. Li Y. et al. (2008) Upregulation of decorin by FXR in vascular smooth muscle cells. Biochem Biophys Res Commun 372: 746–751.
19. Iozzo R.V. (1998) Matrix proteoglycans: from molecular design to cellular function. Ann Rev Biochem 67: 609–652.
20. Iozzo R.V. Schaefer L. (2010) Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277: 3864–3875.
21. Jarvelainen H.T. Iruela-Arispe M.L. Kinsella M.G. Sandell L.J. Sage E.H. Wight T.N. (1992) Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 203: 395–401.
22. Jarvelainen H.T. Kinsella M.G. Wight T.N. Sandell L.J. (1991) Differential expression of small chondroitin / dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 266: 23274–23281.
23. Jeziorska M. McCollum C. Woolley D.E. (1998) Calcification in atherosclerotic plaque of human carotid arteries: associations with mast cells and macrophages. J Pathol 185: 10–17.
24. Kolodgie F.D. Burke A.P. Farb A. Weber D.K. Kutys R. Wight T.N. et al. (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thrombosis Vasc Biol 22: 1642–1648.
25. Lee R.T. Yamamoto C. Feng Y. Potter-Perigo S. Briggs W.H. Landschulz K.T. et al. (2001) Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem 276: 13847–13851.
26. Mehta J.L. Chen J. Hermonat P.L. Romeo F. Novelli G. (2006) Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69: 36–45.
27. Merrilees M.J. Beaumont B. Scott L.J. (2001) Comparison of deposits of versican, biglycan and decorin in saphenous vein and internal thoracic, radial and coronary arteries: correlation to patency. Coronary Artery Dis 12: 7–16.
28. Nelimarkka L. Salminen H. Kuopio T. Nikkari S. Ekfors T. Laine J. et al. (2001) Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 158: 345–353.
29. Nili N. Cheema A.N. Giordano F.J. Barolet A.W. Babaei S. Hickey R. et al. (2003) Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol 163: 869–878.
30. Pluddemann A. Neyen C. Gordon S. (2007) Macrophage scavenger receptors and host-derived ligands. Methods (San Diego, CA) 43: 207–217.
31. Pulkkinen L. Kainulainen K. Krusius T. Makinen P. Schollin J. Gustavsson K.H. et al. (1990) Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J Biol Chem 265: 17780–17785.
32. Radhakrishnamurthy B. Tracy R.E. Dalferes E.R. Jr Berenson G.S. (1998) Proteoglycans in human coronary arteriosclerotic lesions. Exp Mol Pathol 65: 1–8.
33. Ranjzad P. Salem H.K. Kingston P.A. (2009) Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease. Gene Therapy 16: 1154–1162.
34. Raymond M.A. Desormeaux A. Laplante P. Vigneault N. Filep J.G. Landry K. et al. (2004) Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on VSMC. FASEB J 18: 705–707.
35. Reed C.C. Iozzo R.V. (2002) The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconjugate J 19: 249–255.
36. Riessen R. Isner J.M. Blessing E. Loushin C. Nikol S. Wight T.N. (1994) Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 144: 962–974.
37. Roger V.L. Go A.S. Lloyd-Jones D.M. Adams R.J. Berry J.D. Brown T.M. et al. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2011) Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation 123 (4): e18–e209.
38. Santiago-Garcia J. Kodama T. Pitas R.E. (2003) The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J Biol Chem 278: 6942–6946.
39. Schonherr E. Levkau B. Schaefer L. Kresse H. Walsh K. (2001) Decorin-mediated signal transduction in endothelial cells. Involvement of Akt / protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem 276: 40687–40692.
40. Schonherr E. Levkau B. Schaefer L. Kresse H. Walsh K. (2002) Decorin affects endothelial cells by Akt-dependent and -independent pathways. Ann NY Acad Sci 973: 149–152.
41. Schonherr E. O'Connell B.C. Schittny J. Robenek H. Fastermann D. Fisher L.W. et al. (1999) Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 78: 44–55.
42. Schonherr E. Sunderkotter C. Iozzo R.V. Schaefer L. (2005) Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 280: 15767–15772.
43. Schonherr E. Sunderkotter C. Schaefer L. Thanos S. Grassel S. Oldberg A. et al. (2004) Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res 41: 499–508.
44. Seidler D.G. Dreier R. (2008) Decorin and its galactosaminoglycan chain: extracellular regulator of cellular function? IUBMB Life 60: 729–733.
45. Strom A. Ahlqvist E. Franzen A. Heinegard D. Hultgardh-Nilsson A. (2004) Extracellular matrix components in atherosclerotic arteries of Apo E / LDL receptor deficient mice: an immunohistochemical study. Histol Histopathol 19: 337–347.
46. Weber C. (2005) Platelets and chemokines in atherosclerosis: partners in crime. Circulat Res 96: 612–616.
47. Williams K.J. (2001) Arterial wall chondroitin sulfate proteoglycans: diverse molecules with distinct roles in lipoprotein retention and atherogenesis. Curr Opin Lipidol 12: 477–487.
48. Williams K.J. Tabas I. (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler Thrombosis Vasc Biol 15: 551–561.
49. Wong A.P. Nili N. Strauss B.H. (2005) In vitro differences between venous and arterial-derived smooth muscle cells: potential modulatory role of decorin. Cardiovasc Res 65: 702–710.
50. Wu J. Utani A. Endo H. Shinkai H. (2001) Deficiency of the decorin core protein in the variant form of Ehlers–Danlos syndrome with chronic skin ulcer. J Dermatol Sci 27 (2): 95–103.
51. Xaus J. Comalada M. Cardo M. Valledor A.F. Celada A. (2001) Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 98: 2124–2133.
52. Yamakawa T. Bai H.Z. Masuda J. Sawa Y. Shirakura R. Ogata J. et al. (2000) Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas. Atherosclerosis 152: 287–297.
53. Yan J. Stringer S.E. Hamilton A. Charlton-Menys V. Gotting C. Muller B. et al. (2011) Decorin GAG synthesis and TGF-beta signaling mediate Ox-LDL-induced mineralization of human vascular smooth muscle cells. Arterioscler Thrombosis Vasc Biol 31: 608–615.
54. Zamfir A.D. Flangea C. Sisu E. Seidler D.G. Peter-Katalinic J. (2011) Combining size-exclusion chromatography and fully automated chip-based nanoelectrospray quadrupole time-of-flight tandem mass spectrometry for structural analysis of chondroitin / dermatan sulfate in human decorin. Electrophoresis 32: 1639–1646.
55. Zhu J.X. Goldoni S. Bix G. Owens R.T. McQuillan D.J. Reed C.C. et al. (2005) Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem 280: 32468–32479.